
Four of the earliest U.S. cases of a rare inflammatory syndrome in kids with COVID-19 are described in a study that offers insight into the condition. The four children — aged 5, 10, 12 and 13 — arrived at Mount Sinai Hospital in New York City with what is known as exaggerated cytokine storm, an abnormal autoimmune response to the new coronavirus. Nasal swab tests for the virus were negative, but antibody testing confirmed previous COVID-19 infection. The previously healthy children were admitted to the pediatric intensive care unit and were given intravenous immunoglobulin and tocilizumab, an immunosuppressive drug often used to treat rheumatoid arthritis. Study co-author Dr. Jennifer Sanders said severe reactions to COVID-19 infection in kids remain rare. But even if their initial infection was very mild, some become critically ill several weeks later due to this exaggerated immune response. It’s known as multisystem inflammatory syndrome in children, or MIS-C. Sanders is an assistant professor of emergency medicine and pediatrics at Icahn School of Medicine at Mount Sinai. The cases underscore the need for emergency doctors to be on the lookout for the syndrome among kids who have been infected with COVID-19, even if they initially appear to be well, said Dr. Temima Waltuch, a pediatric emergency medicine fellow. “This syndrome appears to be its own entity but patients are presenting with symptoms… read on >